FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alan Gamis

Research Profile

Disorders

Living Beings

Procedures

Antineoplastic Combined Chemotherapy Protocols

Concepts & Ideas

Physiology

Mutation

Occupations

Medical Oncology

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Alan S Gamis; Soheil Meshinchi; John P Perentesis; Todd A Alonzo
Children's Oncology Group's 2013 blueprint for research: Acute myeloid leukemia.
Lillian Sung; Todd A Alonzo; Richard Aplenc; Robert B Gerbing; Thomas Lehrnbecher; Alan S Gamis
Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group.
Leslie Mortland; Jessica A Pollard; Stanley Pounds; Susana Raimondi; Raul C Ribeiro; Jeffrey E Rubnitz; Roland B Walter; Todd A Alonzo; Xueyuan Cao; Janet Franklin; Alan S Gamis; Robert B Gerbing; Betsy Hirsch; Michael R Loken; Soheil Meshinchi; Amit K Mitra; Jatinder Lamba
Clinical significance of CD33 nonsynonymous single-nucleotide polymorphisms in pediatric patients with acute myeloid leukemia treated with gemtuzumab-ozogamicin-containing chemotherapy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alan Gamis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Alan S Gamis; Soheil Meshinchi; John P Perentesis; Todd A Alonzo
Children's Oncology Group's 2013 blueprint for research: Acute myeloid leukemia.
Pediatric blood & cancer 2013;60(6):964-71.
2013: Lillian Sung; Todd A Alonzo; Richard Aplenc; Robert B Gerbing; Thomas Lehrnbecher; Alan S Gamis
Effectiveness of supportive care measures to reduce infections in pediatric AML: a report from the Children's Oncology Group.
Blood 2013;121(18):3573-7.
2013: Leslie Mortland; Jessica A Pollard; Stanley Pounds; Susana Raimondi; Raul C Ribeiro; Jeffrey E Rubnitz; Roland B Walter; Todd A Alonzo; Xueyuan Cao; Janet Franklin; Alan S Gamis; Robert B Gerbing; Betsy Hirsch; Michael R Loken; Soheil Meshinchi; Amit K Mitra; Jatinder Lamba
Clinical significance of CD33 nonsynonymous single-nucleotide polymorphisms in pediatric patients with acute myeloid leukemia treated with gemtuzumab-ozogamicin-containing chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(6):1620-7.
2013: Chelsea J Gudgeon; Kimberly H Harrington; Betsy A Hirsch; George S Laszlo; Soheil Meshinchi; Susana C Raimondi; Todd A Alonzo; Alan S Gamis; Robert B Gerbing; Roland B Walter
High expression of neutrophil elastase predicts improved survival in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.
Leukemia & lymphoma 2013;54(1):202-4.
2012: Alan S Gamis; Franklin O Smith
Transient myeloproliferative disorder in children with Down syndrome: clarity to this enigmatic disorder.
British journal of haematology 2012;159(3):277-87.
2012: Lillian Sung; Todd A Alonzo; Richard Aplenc; Alan S Gamis; Robert B Gerbing
Predictors and short-term outcomes of hyperleukocytosis in children with acute myeloid leukemia: a report from the Children's Oncology Group.
Haematologica 2012;97(11):1770-3.
2012: April D Sorrell; Jeffrey W Taub; William G Woods; Todd A Alonzo; Robert J Arceci; Dorothy Barnard; Robert B Gerbing; Lois Hathaway; Joanne M Hilden; Thomas W Loew; Yaddanapudi Ravindranath; Franklin O Smith; Alan S Gamis
Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group.
Cancer 2012;118(19):4806-14.
2012: Matthew A Kutny; Richard A Larson; Kristina Laumann; Barry K Moser; Bayard L Powell; Wendy Stock; Cheryl L Willman; William G Woods; James Feusner; Alan S Gamis; John Gregory; Soheil Meshinchi
FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology Group.
Pediatric blood & cancer 2012;59(4):662-7.
2012: Michael R Loken; Laura Pardo; Susana C Raimondi; Todd A Alonzo; Todd M Cooper; Janet Franklin; Alan S Gamis; Robert B Gerbing; Betsy A Hirsch; Phoenix Anh-Dung Ho; Soheil Meshinchi
Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group.
Blood 2012;120(8):1581-8.
2012: Richard Aplenc; David Bertoch; B T Fisher; Robert B Gerbing; M Hall; Y S Huang; R Keren; Y Li; A E Seif; L Sung; Peter Charles Adamson; Todd A Alonzo; Alan S Gamis
Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group.
Pharmacoepidemiology and drug safety 2012;21 Suppl 2():37-43.
2012: Jessica A Pollard; Susana C Raimondi; Roland B Walter; Todd A Alonzo; Irwin D Bernstein; Janet Franklin; Alan S Gamis; Robert B Gerbing; Betsy Hirsch; Phoenix Anh-Dung Ho; Michael Loken; Soheil Meshinchi
Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML.
Blood 2012;119(16):3705-11.
2011: Phoenix Anh-Dung Ho; Craig A Hurwitz; Kenneth J Kopecky; Julia Kuhn; Todd A Alonzo; Jeanne E Anderson; Frederick R Appelbaum; Irwin D Bernstein; Janet L Franklin; Alan S Gamis; Robert B Gerbing; John E Godwin; Betsy A Hirsch; Kristen L Miller; Vivian G Oehler; Stephen H Petersdorf; Jerald P Radich; Susana C Raimondi; Gregory H Reaman; Rhonda E Ries; Derek L Stirewalt; Cheryl L Willman; Rong Zeng; Soheil Meshinchi
Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG.
Blood 2011;118(17):4561-6.
2011: Phoenix Anh-Dung Ho; Jason Joaquin; Matthew A Kutny; Todd A Alonzo; Alan S Gamis; Robert B Gerbing; Susana C Raimondi; Soheil Meshinchi
Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group.
Pediatric blood & cancer 2011;57(2):204-9.
2011: J N Berman; J L Franklin; Alan S Gamis; Robert B Gerbing; Nyla A Heerema; B Hirsch; Phoenix Anh-Dung Ho; C Hurwitz; B Lange; K Miller; Susana C Raimondi; Todd A Alonzo; Soheil Meshinchi
Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group.
Leukemia 2011;25(6):1039-42.
2011: Phoenix Anh-Dung Ho; Julia Kuhn; Robert B Gerbing; Jessica A Pollard; Rong Zeng; Kristen L Miller; Nyla A Heerema; Susana C Raimondi; Betsy A Hirsch; Janet L Franklin; Beverly Lange; Alan S Gamis; Todd A Alonzo; Soheil Meshinchi
WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(6):704-11.
2010: Roland B Walter; Todd A Alonzo; Robert B Gerbing; Phoenix Anh-Dung Ho; Franklin O Smith; Susana C Raimondi; Betsy A Hirsch; Alan S Gamis; Janet L Franklin; Craig A Hurwitz; Michael R Loken; Soheil Meshinchi
High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(17):2831-8.
2009: Lillian Sung; Alan S Gamis; Todd A Alonzo; Allen Buxton; Kristen Britton; Joetta DeSwarte-Wallace; William G Woods
Infections and association with different intensity of chemotherapy in children with acute myeloid leukemia.
Cancer 2009;115(5):1100-8.
2008: Amy M Linabery; Cindy K Blair; Alan S Gamis; Andrew F Olshan; Nyla A Heerema; Julie A Ross
Congenital abnormalities and acute leukemia among children with Down syndrome: a Children's Oncology Group study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(10):2572-7.
2008: Cindy K Blair; Michelle Roesler; Yang Xie; Alan S Gamis; Andrew F Olshan; Nyla A Heerema; Leslie L Robison; Julie A Ross
Vitamin supplement use among children with Down's syndrome and risk of leukaemia: a Children's Oncology Group (COG) study.
Paediatric and perinatal epidemiology 2008;22(3):288-95.
2007: Alice Norton; Chris Fisher; Hui Liu; Qiang Wen; Gina Mundschau; Jose Luis Fuster; Henrik Hasle; Bernward Zeller; David K H Webb; Aengus O'Marcaigh; April Sorrell; Joanne Hilden; Alan S Gamis; John D Crispino; Paresh Vyas
Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.
Blood 2007;110(3):1077-9.
2006: Amy M Linabery; Andrew F Olshan; Alan S Gamis; Franklin O Smith; Nyla A Heerema; Cindy K Blair; Julie A Ross
Exposure to medical test irradiation and acute leukemia among children with Down syndrome: a report from the Children's Oncology Group.
Pediatrics 2006;118(5):e1499-508.
2005: Alan S Gamis
Surveys: a tool to provoke thought and identify areas of need.
Pediatric blood & cancer 2005;44(3):205-6.
2005: Alan S Gamis
Acute myeloid leukemia and Down syndrome evolution of modern therapy--state of the art review.
Pediatric blood & cancer 2005;44(1):13-20.
2003: Marianne E Greene; Gina Mundschau; Joshua Wechsler; A MICHAEL MCDEVITT; Alan S Gamis; Judith E Karp; Sandeep Gurbuxani; Robert J Arceci; John D Crispino
Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.
Blood cells, molecules & diseases 2003;31(3):351-6.
2003: Alan S Gamis; William G Woods; Todd A Alonzo; Allen B Buxton; Beverly Lange; Dorothy R Barnard; Stuart Gold; Franklin O Smith
Increased age at diagnosis has a significantly negative effect on outcome in children with Down syndrome and acute myeloid leukemia: a report from the Children's Cancer Group Study 2891.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(18):3415-22.
2003: Robert J Wells; Mary T Adams; Todd A Alonzo; Robert J Arceci; Jonathan Buckley; Allen B Buxton; Kathryn E Dusenbery; Alan S Gamis; Margaret Masterson; Terry Vik; Phyllis Warkentin; James A Whitlock
Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2940-7.
2003: Gina Mundschau; Sandeep Gurbuxani; Alan S Gamis; Marianne E Greene; Robert J Arceci; John D Crispino
Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis.
Blood 2003;101(11):4298-300.
2002: Alan S Gamis; Joanne M Hilden
Transient myeloproliferative disorder, a disorder with too few data and many unanswered questions: does it contain an important piece of the puzzle to understanding hematopoiesis and acute myelogenous leukemia?
Journal of pediatric hematology/oncology 2002;24(1):2-5.
2000: Alan S Gamis; William B Howells; J DeSwarte-Wallace; James Feusner; Jonathan D Buckley; William G Woods
Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia: a report from the Children's cancer group study CCG-2891.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(9):1845-55.